American Vanguard Corp (AVD) 16.64 $AVD Upgrade Alert

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
American Vanguard Corp (AVD) 16.64 $AVD

Upgrade Alert for American Vanguard (AVD)
Comtex SmarTrend(R) - Thu Aug 04, 3:45AM CDT
American Vanguard (NYSE:AVD) was upgraded from Neutral to Buy at SunTrust today. The stock closed yesterday at $17.37 on volume of 695,000 shares, above average daily volume of 250,000. Based on a current price of $17.37, American Vanguard is currently 15.9% above its average consensus analyst price target of $14.60. The stock should find initial support at its 50-day moving average (MA) of $15.59 and further support at its 200-day MA of $13.47.
AVD: 16.64 (-0.11)

Ecolab's (ECL) Q2 Earnings in Line, FY16 View Lowered
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:56PM CDT
Ecolab Inc. (ECL) reported adjusted earnings of $1.08 per share in the second quarter of 2016 which was in line with the Zacks Consensus Estimate.
FOE: 13.47 (-0.01), AVD: 16.64 (-0.11), CHMT: 29.85 (-0.42), ECL: 123.70 (-0.35)

American Vanguard Reports Second Quarter & Mid-Year 2016 Results
BusinessWire - Tue Aug 02, 3:05PM CDT
American Vanguard Corporation (NYSE:AVD) today announced financial results for the second quarter and six-month period ended June 30, 2016.
AVD: 16.64 (-0.11)

American Vanguard International Subsidiary and Huifeng Agrochemical Company Ltd. Subsidiary Establish Agro-Technology Joint Venture
BusinessWire - Tue Aug 02, 8:00AM CDT
American Vanguard Corporation (NYSE:AVD) today announced that its International Subsidiary, AMVAC Netherlands BV, has joined with Chinese-based Huifeng Agrochemical Company, Ltd. Subsidiary Shanghai Focus Biological Technology Co., Ltd. to establish a technology R&D-focused joint venture based in Hong Kong. This enterprise, Huifeng AMVAC Innovation Co., Limited will focus on technology transfer between the co-owners, including the development of new, proprietary agrochemical formulations and precision application systems for crop protection.
AVD: 16.64 (-0.11)

Chemical Stocks Q2 Earnings on Aug 2: FMC, ECL, IOSP, AVD
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 8:58AM CDT
We take a look at four chemical companies that are scheduled to report their quarterly results on Aug 2.
CE: 64.36 (-0.23), IOSP: 59.30 (-0.66), AVD: 16.64 (-0.11), FMC: 46.71 (-0.80), DD: 69.69 (-0.40), DOW: 53.90 (-0.28), PPG: 107.62 (+0.58), APD: 157.40 (+0.31), ECL: 123.70 (-0.35)

American Vanguard Declares Quarterly Dividend
BusinessWire - Mon Jun 13, 8:00AM CDT
American Vanguard Corp. (NYSE:AVD) announced that its Board of Directors has declared a $0.01 cash dividend payment to be distributed on July 12, 2016 to shareholders of record as of June 30, 2016.
AVD: 16.64 (-0.11)

American Vanguard (AVD) Is in Oversold Territory: What's Next?
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:36AM CDT
American Vanguard Corp. (AVD) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
AVD: 16.64 (-0.11)

International Flavors & Fragrances (IFF) Beats Q1 Earnings
Zacks Equity Research - Zacks Investment Research - Tue May 10, 7:36AM CDT
International Flavors & Fragrances Inc. (IFF) reported better-than-expected earnings for first-quarter 2016. Adjusted earnings came in at $1.47 per share, above the Zacks Consensus Estimate of $1.41.
IFF: 138.77 (-0.22), KMG: 27.91 (-0.62), DQ: 24.86 (-0.01), AVD: 16.64 (-0.11)

Downgrade Alert for American Vanguard (AVD)
Comtex SmarTrend(R) - Thu May 05, 3:12AM CDT
American Vanguard (NYSE:AVD) was downgraded from Buy to Neutral at Roth Capital today. The stock closed yesterday at $13.27 on volume of 990,000 shares, above average daily volume of 219,000. Over the past year, American Vanguard has traded in a range of $9.63 to $17.41 and closed yesterday at $13.27, 38% above that low. The 200-day and 50-day moving averages have moved 0.30% higher and 1.13% higher over the past week, respectively.
AVD: 16.64 (-0.11)

American Vanguard Reports First Quarter 2016 Results
BusinessWire - Tue May 03, 3:05PM CDT
American Vanguard Corporation (NYSE:AVD), today announced financial results for the quarter ended March 31, 2016.
AVD: 16.64 (-0.11)

American Vanguard Shares Up 45.4% Since SmarTrend's Buy Recommendation (AVD)
Comtex SmarTrend(R) - Fri Apr 29, 12:58PM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 3 months, American Vanguard has returned 45.44% as of today's recent price of $16.90.
AVD: 16.64 (-0.11)

Uptrend Call Working As American Vanguard Stock Rises 39.8% (AVD)
Comtex SmarTrend(R) - Thu Apr 21, 12:54AM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 3 months, American Vanguard has returned 39.76% as of today's recent price of $16.24.
AVD: 16.64 (-0.11)

Shares of AVD Up 34.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Apr 13, 1:27PM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 2 months, American Vanguard has returned 34.77% as of today's recent price of $15.66.
AVD: 16.64 (-0.11)

American Vanguard Shares Up 37.3% Since SmarTrend's Buy Recommendation (AVD)
Comtex SmarTrend(R) - Tue Mar 29, 1:19PM CDT
SmarTrend identified an Uptrend for American Vanguard (NYSE:AVD) on February 5th, 2016 at $11.62. In approximately 2 months, American Vanguard has returned 37.26% as of today's recent price of $15.95.
AVD: 16.64 (-0.11)

PPG Industries-Bridgestone Project Gets Funds from DOE
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 3:15PM CST
PPG Industries Inc. (PPG) said that the U.S. Department of Energy is funding its $1.25 million collaborative project with Bridgestone Americas, Inc.
AVD: 16.64 (-0.11), PPG: 107.62 (+0.58)

PPG to Showcase Substrate-Protection Products at ECOAT16
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 4:30PM CST
PPG Industries (PPG) will showcase a range of integrated substrate-protection products and also present five technical papers at ECOAT16.
AVD: 16.64 (-0.11), PPG: 107.62 (+0.58)

LyondellBasell (LYB) Wraps Up Petroken Unit Sale to GIP
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 3:04PM CST
LyondellBasell (LYB) has completed the sale of its Argentina-based fully-owned unit Petroken to Grupo Inversor Petroquimica S.L.
KMG: 27.91 (-0.62), LYB: 79.47 (-0.25), AVD: 16.64 (-0.11)

Albemarle Closes Sale of Businesses to J.M. Huber Unit
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 2:20PM CST
Albemarle (ALB) has wrapped up the sale of its Mineral Flame Retardants and Specialty Chemicals businesses to J.M. Huber's unit Huber Engineered Materials.
KMG: 27.91 (-0.62), ALB: 83.04 (+1.08), AVD: 16.64 (-0.11)

Shares of AVD Down 21.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Feb 03, 4:12PM CST
SmarTrend identified a Downtrend for American Vanguard (NYSE:AVD) on December 14th, 2015 at $13.56. In approximately 2 months, American Vanguard has returned 21.28% as of today's recent price of $10.67.
AVD: 16.64 (-0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Conformal Coatings Market Set for Significant Growth by 2032

Updated Category News Views 233

The conformal coatings market surged ahead with projections showing it could reach USD 1.7 billion by 2032. This translates into a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032, driven primarily by advancements in electronic protection technologies. Traders had better keep their eyes peeled—this ain't just a bump; it's a substantial shift. What’s...

Continue Reading
Japanese Mobile Battery Industry Forecasts Significant Growth

Updated Category News Views 122

Japan Mobile Battery Market Overview The mobile battery market in Japan is witnessing significant growth, with a valuation of JPY 207.96 billion in 2024 and projected to escalate to JPY 358.97 billion by 2033, marking a compound annual growth rate (CAGR) of 6.48% from 2025 to 2033. This growth trajectory highlights not only increasing consumer demands but also rapidly...

Continue Reading
Givastomig: A Promising Player in Gastric Cancer Therapy

Updated Category News Views 74

Givastomig's Advances in Gastric Cancer Research I-Mab (NASDAQ: IMAB), a biotech firm focused on developing cancer immunotherapies, recently presented exciting results from its Phase 1 clinical trial involving givastomig. This innovative bispecific antibody immunostimulant was unveiled at a prominent medical conference, demonstrating its effectiveness in treating advanced...

Continue Reading
Rani Therapeutics Partners with Chugai for Drug Delivery Breakthrough

Updated Category News Views 245

Rani Therapeutics Engages with Chugai Pharmaceutical Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) recently announced a significant collaborative effort with Chugai Pharmaceutical Co., Ltd., resulting in an enthusiastic response from investors. This collaboration aims to utilize Rani's innovative RaniPill oral drug delivery system alongside Chugai's experimental...

Continue Reading
Revizto's Brand Revamp: A Bold Step Towards Future Growth

Updated Category News Views 142

Revizto Introduces a Fresh Brand Identity As project complexities continue to rise in the construction industry, Revizto is making important modifications to its public image. The renowned collaboration platform, specifically designed for the Architecture, Engineering, Construction, and Operations (AECO) sectors, recently unveiled its refreshed brand identity,...

Continue Reading